Clinical trial / 2007
Intragastric balloon increases temporary satiety without altering plasma ghrelin in morbid obesity.
In a 4-month randomized sham-controlled trial of 21 patients with morbid obesity, weight decreased significantly in both balloon (143.8 to 131.1 kg) and sham groups (138.8 to 129.9 kg), with no significant difference between groups. The intragastric balloon caused a temporary rise in pre- and postprandial satiety peaking at 4 weeks. However, fasting, postprandial, and area under the curve ghrelin levels did not differ between groups and did not correlate with satiety scores.
- Study type
- Randomized controlled trial
- Who was studied
- 21 adults with treatment-resistant morbid obesity (mean BMI 50.4 kg/m2)
- What was measured
- Satiety, plasma ghrelin levels, and body weight
THE PAPER
Intragastric balloon-induced satiety is not mediated by modification in fasting or postprandial plasma ghrelin levels in morbid obesity.
Martinez-Brocca MA, Belda O, Parejo J, Jimenez L, del Valle A, Pereira JL, Garcia-Pesquera F, Astorga R, Leal-Cerro A, Garcia-Luna PP. Obes Surg, 2007.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.